Walter Hess
Host
Replay available
DocMorris AG (LSE: 0RRB) Q4 2024 earnings conference call, held 2025-03-13. Replay captured from the company's public earnings webcast.

Host
CFO
Analyst, UBS
Analyst, Deutsche Bank
Analyst, Stiefel
Analyst, Research Partners
Analyst, ZKB
Analyst, Warburg Research
Watch the replay and follow the connected company analysis, news, and investor updates for Docmorris Ltd.
WEBVTT 00:00:00.301 -- 00:00:05.427 Hello, ladies and gentlemen, and welcome to the DocMorris AG 2020 for 00:00:05.427 -- 00:00:08.770 full year results and Outlook 2025. 00:00:08.770 -- 00:00:12.735 At this time, all participants have been placed on a listen-only mode. 00:00:12.735 -- 00:00:16.817 The floor will be open for questions following the presentation. 00:00:16.839 -- 00:00:21.302 Let me now turn the floor over to your host, Walter Hess. 00:00:21.444 -- 00:00:27.217 Yeah, thank you very much and good morning to everybody to today's conference call. 00:00:27.217 -- 00:00:33.003 The full year results 24 will be presented by Daniel Wurst, our new CFO, 00:00:33.003 -- 00:00:35.123 and myself. 00:00:35.645 -- 00:00:40.850 We will share insights and updates across all segments and provide a comprehensive 00:00:40.850 -- 00:00:43.913 overview of our business performance. 00:00:43.913 -- 00:00:49.739 So we will start with a business update, followed by a financial update, and conclude 00:00:49.739 -- 00:00:56.043 with our outlook. Thereafter, we are looking forward to answering your questions. 00:00:56.258 -- 00:01:00.323 Let us start with the highlights of last year. 00:01:00.323 -- 00:01:02.265 In 2024, we 00:01:02.265 -- 00:01:07.131 achieved significant milestones again. Since 00:01:07.131 -- 00:01:11.136 the introduction of CardLink in April 24, 00:01:11.136 -- 00:01:16.562 there has been a five-fold increase in new Rx customers. 00:01:16.562 -- 00:01:19.746 These new customers show significantly 00:01:19.746 -- 00:01:25.610 improved KPIs compared to our former PRx customers. 00:01:26.043 -- 00:01:31.050 We are very pleased to announce that in 2024, we reached 00:01:31.050 -- 00:01:35.936 profitability with our non-Rx business. 00:01:35.936 -- 00:01:40.983 It ...